Crossref

1. Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2

- Tasshitra Subramaniam

- Siti Aisyah Mualif

- Weng Howe Chan

- Khairul Bariyyah Abd Halim

2. Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development

- Parisa Ghasemiyeh

- Soliman Mohammadi-Samani